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The mechanism of Bax-dependent cytochrome c release is still controversial and may also depend on the actual localisation of cytochrome
c: (i) we studied the distribution of cytochrome c in sub-fractions of rat kidney mitochondria and found that 10–20% of the total cytochrome
c was associated at the peripheral inner membrane and to some extent organised in the contact sites. (ii) Cytochrome c concentrations in the
contact site fractions varied related to surface bound hexokinase activity. It decreased upon reduction of contact sites by glycerol or specific
dissociation of the VDAC–ANT complexes by bongkrekate, whereas it increased upon induction of contacts by dextran or association of
VDAC–ANT complexes by atractyloside. (iii) The outer membrane pore (VDAC) acquires high capacity for hexokinase binding by
interacting with the ANT. Thus, surface-attached hexokinase protein indicated the frequency of VDAC–ANT complexes and the correlation
between hexokinase activity and cytochrome c suggested association of the latter to the complexes. (iv) Substances affecting exclusively the
structure of either hexokinase (glucose-6P) or cytochrome c (borate) led to a decrease only of the effected protein without changing the
concentration of other contact site constituents. (v) Hexokinase was furthermore used as a tool to isolate the contact site forming complex of
outer membrane VDAC and inner membrane ANT from Triton-dissolved membranes. Cytochrome c remained attached to the hexokinase
VDAC–ANT complexes that were reconstituted in phospholipid vesicles. (vi) The vesicles were loaded with malate and BaxDC released the
endogenous cytochrome c from the reconstituted complexes without forming unspecific pores for malate. BaxDC targeted a cytochrome c
fraction associated at the VDAC–ANT complex. The cytochrome c organisation was dependent on the actual structure of VDAC and ANT.
Thus, the BaxDC effect was suppressed either by hexokinase utilising glucose and ATP or by bongkrekic acid both influencing the pore and
ANT structure.
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1. Introduction c release is the pro-apoptotic Bcl-2 family member Bax (forThere are several signal- and tissue-specific pathways to
induce apoptosis. One signal is the release of cytochrome c
from mitochondria [1–3] that activates caspases [2] by
binding to a cytoplasmic protein Apaf-1 in presence of
dATP [4]. An important stimulus which causes cytochrome0167-4889/$ - see front matter D 2003 Elsevier B.V. All rights reserved.
doi:10.1016/j.bbamcr.2003.10.007
* Corresponding author. Tel.: +49-7531-88-4112; fax: +49-7531-88-
4257.
E-mail address: Dieter.Brdiczka@uni-konstanz.de (D. Brdiczka).review see Ref. [5]). It is synthesised in the cytoplasm and
translocated to mitochondria [6] where it releases cyto-
chrome c [7,8].
The mechanism by which Bax releases cytochrome c
from the mitochondrial inter-membrane space into the
cytoplasm is still controversial. Some results indicate that
Bax induces permeability transition (PT), leading to swell-
ing of mitochondria, followed by rupture of the outer
membrane and release of several factors into the cytoplasm
[9]. In many cases of apoptosis, mitochondrial depolarisa-
tion, swelling and release of larger proteins occurs as a late
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cases, Bax-induced cytochrome c release appears to be more
selective: (i) it amounts to approximately 20% of the total
cytochrome c, (ii) it is not dependent on outer membrane
disruption and PT.
Full-length Bax itself formed pores for small molecules
in synthetic bilayers [11,12] and after reconstitution in
liposomes [13]. In contrast, BaxDC did not form pores
permeable for cytochrome c in outer membranes free of
contact sites or vesicles with reconstituted VDAC [14], but
was well able to release cytochrome c from intact mito-
chondria [7,8].
So far, most investigations have not thought of the
cytochrome c compartmentation and a possible different
organisation in intact mitochondria compared to lipid
vesicles. Considering the new mitochondrial structure
model [15,16], we suggest that different fractions of
cytochrome c associated to different membrane areas of
the inner membrane have to be regarded such as cristae
membranes, inner boundary membrane and contact sites in
addition. Energy transferring contact sites are formed by
interaction between the outer membrane pore (VDAC) and
the ANT [17–19]. VDAC, being in a complex with ANT,
exerts higher capacity for hexokinase binding [20] com-
pared to VDAC beyond the contact sites. Thus, hexoki-
nase could be used as an indicator of VDAC–ANT
complexes and a marker enzyme of contact sites [21,22].
The complex between hexokinase, VDAC and ANT is
relatively stable as it remains intact in a Triton extract of
mitochondrial membranes from rat brain [23]. This obser-
vation led us to use the enzyme as an instrument to
separate by anion exchange chromatography the hexoki-
nase contact sites from other contact site-forming com-
plexes such as the VDAC creatine kinase ANT complex.
When the different contact sites were reconstituted into
phospholipid vesicles, hexokinase as well as creatine
kinase was functionally coupled to the ANT, phosphory-
lating external glucose or creatine by utilising internal ATP
[23]. This process could be blocked by ANT inhibitors
bongkrekate or atractyloside.
It will be shown that a significant amount (20% of
total) of cytochrome c is associated with the hexokinase-
containing contact sites. It was therefore tempting to
study the effect of Bax exclusively on this cytochrome c
fraction by applying the known technique of isolation
and reconstitution of the hexokinase VDAC–ANT com-
plexes [23,24]. This was particularly interesting as recent
investigations showed that Bax and hexokinase compete
for the same binding sites in hepatocyte mitochondria
[25]. Furthermore, protein kinase B linked suppression
of cytochrome c release and apoptosis was found to
depend on the activity of mitochondrial bound hexoki-
nase [26,27]. In general, we assumed that this contact
site fraction could be the mitochondrial cytochrome c
pool specifically releasable in the early period of Bax
action [28].2. Material and methods
2.1. Materials
All reagents were purchased from Sigma or Roche if not
stated otherwise.
2.1.1. Isolation of kidney mitochondria
The three kidneys from 3–4-month-old male Wistar rat
were homogenised in 30 ml HEPES-sucrose buffer contain-
ing 250 mM sucrose, 10 mM HEPES NaOH pH 7.4, 0.5%
BSA (essential fat-free), 1 mM reduced glutathione (GSH),
1 mM EGTA using a glass Teflon potter homogeniser. The
homogenate was centrifuged for 10 min at 700 g. The
supernatant was centrifuged for 10 min at 7000 g. The
pellet was re-suspended in 15 ml sucrose-dextran buffer
containing the same medium as above but 10% dextran
15,000 in addition. The suspension was centrifuged for 12
min at 700 g. The supernatant was centrifuged for 20 min
at 7000 g. Mitochondria were re-suspended in 200 Al KCl-
Dextran buffer containing 125 mM KCl, 10 mM HEPES pH
7.4, 1 mM GSH.
2.1.2. Isolation of contact site fraction from kidney
mitochondria
Contact sites were isolated by sucrose density gradient
centrifugation from osmotically shocked kidney mito-
chondria according to the method described by Adams
et al. [21]. The method was slightly modified by omitting
the sonification step after osmotic shock and creatine
kinase activity was measured in the presence of 0.2%
Triton X-100.
2.1.3. Isolation of hexokinase porin–ANT complexes from
brain membranes
The method was performed essentially as described
recently [23,24] with slight modifications. Rat brain, stored
frozen, was homogenised by a Teflon potter in isolation
medium (10 mM Hepes, pH 7.4, 100 mM glucose, 1 mM
monothioglycerol) at approximately 10 ml per gram of wet
tissue. The homogenate was centrifuged 10 min at 4 jC
and 10,000 g in a ‘‘Sorvall’’ centrifuge with rotor SS-34.
The pellet was re-suspended in the same volume of
isolation medium and the centrifugation was repeated. This
process removed only 10% of total hexokinase from rat
brain sediment. The last pellet was re-suspended in the
isolation medium containing 1% Triton X-100 and was
incubated for 45 min at room temperature with gentle
stirring. The insoluble membrane material was removed
by centrifugation at 45,000 g in a Beckman L8-M
ultracentrifuge, using rotor TI-50, for 45 min at 4 jC.
The supernatant was incubated with DE 52 cellulose
(Whatman) that had been equilibrated with 5 mM K-
phosphate, pH 8.0, 100 mM glucose, 1 mM dithioerythri-
tol. The DE 52 cellulose was loaded with the extract and
packed as a column, from which hexokinase activity and
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and 400 mM and determined in the fractions by optical test
as described below.
2.1.4. Reconstitution of hexokinase porin–ANT complexes
Lipid mixture used in reconstitution was phosphatidyl-
cholin containing 2% cholesterol. The phospholipid
vesicles, 0.3% n-octyl-h-D-glucoside and 5 ml of the com-
bined hexokinase peak fractions from the DE 52 were mixed
for 20 min at room temperature, followed by overnight
dialysis at 4 jC against 125 mM sucrose and 10 mM Hepes,
pH 7.4. The vesicles were loaded with 10 mM KCl and 5
mM malate by sonification followed by subsequent chro-
matography on Sephadex G 50 using a 24/1 cm column
with a flow rate of 20 ml per hour. The column was
equilibrated in 125 mM sucrose and 10 mM Hepes pH
7.4. After chromatography, the vesicle permeability for
malate was tested. This was performed by centrifugation
of the vesicles for 45 min at 400,000 g followed by malate
determination in the supernatant and sediment.
2.1.5. Enzyme assays
Hexokinase (EC 2.7.1.1) activity was measured in
agreement with Bu¨cher et al. [29]. The enzyme was
determined in a coupled optical enzyme assay with glucose
and ATP as substrates. Bacterial glucose 6-phosphate
dehydrogenase and NADH formation were used as indica-
tor reaction.
The determination of succinate dehydrogenase (SDH)
(EC 1.3.9.9) activity was performed as described in
Brdiczka et al. [30].
Malate was determined by an enzyme assay according to
Bergmeyer [31].
2.1.6. Cytochrome c determination
Cytochrome c was determined in a double beam spec-
trophotometer by difference spectroscopy according to fun-
damental work of Keilin [32]. We used the a band of the
cytochrome c spectrum at 550 nm after reduction of the
cytochrome by Na-dithionite.
Alternatively, cytochrome c was determined by specific
antibodies. Mitochondrial sub-fractions corresponding to 5
Ag protein were separated by TRICINE 12% Poly-acryl-
amide gel electrophoresis (PAGE). Contents of cytochrome
c were estimated by Western blotting using monoclonal
anti-cytochrome c antibody (Pharmingen). Antigen–anti-
body complexes were detected using a horseradish perox-
idase conjugated goat anti-mouse IgG (Sigma) and a
chemi-luminescence kit (ECL + Plus, Amersham). A cali-
bration with horse heart cytochrome c was performed. The
curve was found to be linear between 5 and 25 pmol
cytochrome c.
2.1.7. Assay of protein concentration
Protein was determined by the method of Lowry et al.
[33].2.1.8. Electrophoresis, trans-blot, immune decoration
PAGE was performed according to Laemmli [34] with
100 mM Tris, 100 mM Tricine pH 8.6, 0.1% SDS as
electrode buffer. Electro-transfer and immune-decoration
were performed as described by Rott and Nelson [35].
2.1.9. Bax-DC preparation
Recombinant Bax-DC protein used in the experiments
shown in Fig. 4 was prepared according to Xie et al. [36]
with slight modifications. Briefly, E. coli XL-1 Blue cells
carrying the plasmid pGEX-T1-Bax (1–171) were grown
overnight at 37 jC in 2 l Terrific Broth (TB) medium
supplemented with 1.5% glycerol containing 0.5 mg/ml
carbenicillin. Protein overexpression was induced by the
addition of 10 AM IPTG and performed overnight at room
temperature. The harvested cells were disrupted by lyso-
zyme addition and sonification. After centrifugation
(27,500 g, 10 min) the supernatant was applied to a
glutathione sepharose column (Pharmacia) by overnight
circulation. After extensive washing, the protein was recov-
ered from the column by proteolytic cleavage with thrombin
(Pharmacia). The eluted Bax-DC protein was dialyzed for 4
h in the presence of 10 mM Tris–HCl (pH 8.0), 1 mM
EDTA, and 0.1% 2-mercaptoethanol. The dialyzed protein
was applied to a Resource Q column (Pharmacia) and the
protein was eluted within a linear gradient ranging from 0 to
500 mM NaCl in dialysis buffer. Fractions containing the
Bax-DC protein were concentrated in the presence of 10
mM Tris–HCl (pH 7.5), 100 mM NaCl using a stirred
Amicon cell to a final protein concentration of 0.35 mg/ml.
The Bax-DC protein was stored at  70 jC.
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3.1. Cytochrome c distribution in mitochondrial
sub-fractions
We analysed the distribution of cytochrome c in sub-
fractions of kidney mitochondria obtained by osmotic shock
and subsequent sucrose density centrifugation. This method
leads to a separation of contact sites from inner membrane
fragments and unbroken mitochondria. The contact site
fraction is characterised by high hexokinase activity, where-
as SDH is representative for all fractions containing inner
membrane (Fig. 1A). At low ionic strength, cytochrome c is
not detached from the membranes. Thus, in sucrose-based
medium used here, even after rupture of the mitochondrial
membranes cytochrome c remained bound where it was
before disruption. Cytochrome c was determined by im-
mune reaction. The amount of cytochrome c in the different
fractions was calculated from the resulting signal intensity.
While most of the cytochrome c was found in the SDH
activity peak, a significant cytochrome c concentration was
present in the hexokinase activity containing fractions,
representing contact sites. This suggested that the cyto-
Fig. 2. Variation of cytochrome c and hexokinase in kidney mitochondria
by influencing VDAC–ANT complexes. Distribution of inner membrane
(SDH) and contact site (HK) fractions in a sucrose density gradient (54.3%,
left –30.8%, right) that separates sub-fractions of rat kidney mitochondria
after osmotic shock. Cytochrome c concentration (empty circles) in the
different fractions was determined by specific antibodies and varied
significantly in 500 AM atractyloside treated A, compared to 250 AM
bongkrekate treated B.
Fig. 1. Cytochrome c and hexokinase in the contact sites of kidney
mitochondria. Distribution of inner membrane (SDH) and contact site (HK)
fractions in a sucrose density gradient (54.3%, left –30.8%, right) that
separates sub-fractions of rat kidney mitochondria after osmotic shock.
Cytochrome c concentration (empty circles) in the different fractions was
determined by specific antibodies shown below the x-axis in panel A,
control mitochondria. Lower panel, mitochondria treated with 5 mM
glucose-6-phosphate.
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inner membrane has a specific second localisation at the
contact sites.
Contact sites are transient structures that form between
functionally interacting components in the outer membrane,
for example VDAC and in the peripheral inner membrane,
as example ANT. VDAC, interacting with the ANT, has a
higher capacity for hexokinase binding compared to free
porin beyond the contact sites. Hexokinase forms tetramers
in these sites [37,38]. Therefore, the enzyme activity could
be used as a marker for this type of contact sites. However,
hexokinase binding did not induce contact sites [20] mean-
ing that VDAC–ANT complexes could persist even after
de-sorption of hexokinase. Such detachment of hexokinase
was performed with glucose 6-phosphate which changes the
structure of hexokinase and by that leads to lower affinity of
the enzyme. As depicted in Fig. 1B, hexokinase activity
decreased significantly after incubation of mitochondria
with glucose 6-phosphate, but the treatment did not reducecytochrome c in the contact site fractions compared to the
control in Fig. 1A.
3.2. Changes of cytochrome c distribution depending on the
presence of contact sites
Based on the results above, we concluded that a specific
contact site structure might be responsible for cytochrome c
binding. Considering that VDAC–ANT complexes are
involved in contact site formation we studied the cyto-
chrome c distribution under conditions that changed the
structure of the ANT from the c (atractyloside) to the m
(bongkrekate) conformation.
Sub-fractions of kidney mitochondria were prepared and
separated as described above. Atractyloside known to in-
duce contact sites [39,40] resulted in increased hexokinase,
and in parallel, a higher cytochrome c concentration in the
contact site fraction (Fig. 2A). However, pre-incubation
with bongkrekate, which suppresses porin–ANT com-
plexes, lead to a decrease of hexokinase and also of
cytochrome c in the contacts (Fig. 2B).
Fig. 3. Variation of cytochrome c and hexokinase distribution in kidney
mitochondria by changing contact site frequency. Distribution of inner
membrane (SDH) and contact site (HK) fractions in a sucrose density
gradient (54.3%, left –30.8%, right) that separates sub-fractions of rat
kidney mitochondria after osmotic shock. Cytochrome c concentration
(empty circles) in the different fractions was determined by specific
antibodies. (A) Before disruption, mitochondria were pre-incubated with
10% dextran 15. (B) Before osmotic shock, mitochondria were treated with
20% glycerol, or pre-incubated with 5 AM borate C.
Fig. 4. PAGE of contact site fraction and cytochrome c immune decoration
under different treatments. Contact sites from kidney mitochondria were
isolated as described in Materials and methods. Aliquots of the fractions
were run on PAGE. The gels were analysed for protein by silver staining.
The presence of cytochrome c was determined in a second gel by specific
antibodies shown below. The peptide band in the region of Mr 100 kDa,
representing the hexokinase monomer is indicated by a line. Lane
M=molecular weight markers. The other lanes show contact site fractions
of mitochondria pre-treated in different ways: lanes 1 and 2, untreated; lane
3, 500 AM atractyloside; lane 4, 20% glycerol; lane 5, 10 mM glucose-6-P;
lane 6, 250 AM bongkrekate.
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induced by dextran that changes the structure of VDAC
[20,41] and facilitates interactions between outer- and
peripheral inner membrane by exerting an osmotic effect
on the outer compartment. In agreement with these findings,
we observed higher activity of hexokinase in the fractions of
the density gradient that contained the contact sites Fig. 3A.
The opposite result was obtained by depression of thecontact sites with glycerol [42]. In this case, only very
low activity of hexokinase was found in the contact site
fractions (Fig. 3B). Following the cytochrome c distribution
in the different mitochondrial sub-fractions, it was observed
that the cytochrome c concentration in the contact site
fraction was correlated with the hexokinase activity (Figs.
1–3). As bound hexokinase appeared to indicate the pres-
ence of VDAC–ANT complexes, it was assumed that
cytochrome c was associated to the complexes.
To exclude that this indication was erroneous because of
inhibition of hexokinase activity, we analysed the contact
sites by electrophoresis and immune decoration under
different treatments. The results depicted in Fig. 4 com-
pletely agree with that obtained by activity determination.
The peptide band in the region of Mr 100 kDa, representing
the hexokinase monomer, disappeared in the sedimented
contacts under glucose-6-P and bongkrekate treatment.
Cytochrome c, identified by specific antibodies, was absent
in the contact fraction after glycerol and bongkrekate
treatment.
3.3. The peripheral lysine residues of cytochrome c
determine its distribution
It has been described that borate ion interacts with high
affinity with the peripheral lysine residues No. 13 and 86 of
the cytochrome c [43]. We therefore treated kidney mito-
chondria with 5 mM Na-borate followed by the same
procedure as above of osmotic shock and separation of
the sub-fractions by density gradient centrifugation. As
shown in Fig. 3C, hexokinase activity was high in the
contact site fractions, however, cytochrome c decreases
Fig. 5. Elution profile of hexokinase activity and cytochrome c from DEAE
cellulose. Washed rat brain membranes were extracted with 1% Triton X-
100. The extract was bound to a DE 52 cellulose column, as described in
Materials and methods and hexokinase activity (solid line) and cytochrome
c (open circles) was eluted by a KCl gradient between 100 and 400 mM.
Cytochrome c in the fractions was determined by a spectrophotometer.
Fig. 6. Bax-dependent release of endogenous cytochrome c in the
hexokinase porin–ANT complex. (A) The vesicles containing reconstituted
complexes were loaded with 5 mM malate. Release of the entrapped malate
and of endogenous cytochrome c into the supernatant was measured after
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3.4. Isolation of the hexokinase porin–ANT complex and
co-localisation of cytochrome c therein
The results above suggested that cytochrome c may be
organised in the VDAC–ANT complexes. Hexokinase
arranges as a tetramer at VDAC in this complex [38]. The
enzyme can thus be used as a device to isolate the ANT–
VDAC complex from a Triton extract of brain membranes
[23]. Hexokinase in the Triton extract was bound to an
anion exchanger and was eluted by a KCl gradient. Fig. 5
shows the elution profile of hexokinase activity from a DE-
cellulose column. When the concentration of cytochrome c
was determined in the eluted fractions, we observed a
smaller peak running in front of the hexokinase activity,
whereas the largest amount was eluted together with the
hexokinase. In previous investigations, it has been observed
that the hexokinase in these fractions was linked to porin
and the ANT. The hexokinase porin–ANT complexes
reconstituted in phospholipid vesicles functionally resem-
bled the PT pore [23,24].Table 1







50 AM Ca2 + 64 25.6
500 AM Ca2 + 84 30.16
50 AM Ca2 + (100 nM CSA) 19.6 16.87
500 AM Ca2 + (100 nM CSA) 30.3 30.78
Triton X-100 (total) 100 100
incubation of the vesicles at 25 jC for 30 min with increasing
concentrations of Bax-DC in 125 mM sucrose, 10 mM Hepes pH 7. Mean
of three experiments with independent complex preparations. (B) The
experiment was performed as in A except that in some samples, 250 AM
bongkrekate was present. In the samples treated with 250 AM bongkrekate,
cytochrome c was determined in the supernatant (BA sup) and sediment
(BA sed) after centrifugation. Mean of two experiments with two
independent complex preparations. (C) Influence of hexokinase activity
on the Bax-dependent release of endogenous cytochrome c. The vesicles
containing the reconstituted complexes were incubated at 25 jC for 30 min
with increasing concentrations of Bax-DC in 125 mM sucrose, 10 mM
Hepes pH 7.0. 2 mM ATP and 10 mM glucose were added to the samples.
Cytochrome c was determined in supernatant and sediment after
centrifugation. Depicted is a typical example of three experiments.
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stituted hexokinase porin–ANT complex
The hexokinase porin–ANT complex was reconstituted
in phospholipid vesicles. The vesicles were loaded with
malate, which could be released by increasing Ca2 + con-
centrations. In agreement with earlier investigations [23] the
Ca2 +-dependent malate release was inhibited by cyclosporin
A (Table 1), suggesting PT pore-like functions in the
reconstituted complex.
The same malate-containing vesicles with the reconsti-
tuted hexokinase complex were treated with increasing Bax-
DC concentrations. As depicted in Fig. 6A, Bax-DC was
able to liberate the cytochrome c bound in the complex in a
concentration range between 400 and 1000 nM. However,
the malate inside the vesicles was not released.
The Bax-dependent cytochrome c release could be com-
pletely suppressed by incubation of the reconstituted com-
plexes with 250 AM bongkrekate (Fig. 6B). Considering that
bongkrekate reduced contact sites and by that changed the
cytochrome c distribution (Fig. 2B), the results suggested
that Bax-DC at the applied low concentrations liberated
exclusively a fraction of cytochrome c that was organised
within VDAC–ANT complexes constituting contact sites.
3.6. Hexokinase activity suppresses Bax-DC-dependent
cytochrome c release
It has been observed that Bax and hexokinase isotype II
compete for the same binding sites [25]. The ADP produced
by active hexokinase stabilises the porin–ANT complexes
[39], and thus the enzyme stays bound to the mitochondrial
surface. This may explain why Bax-DC was unable to
displace hexokinase and to liberate cytochrome c from the
reconstituted hexokinase porin–ANT complex in the pres-
ence of hexokinase substrates, glucose and ATP (Fig. 6C).
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4.1. Localisation of cytochrome c in mitochondria
Considering the new mitochondrial structure model
[15,16], at least two fractions of cytochrome c were
expected: one fraction at the surface of the cristae mem-
branes and the other bound to the peripheral inner mem-
brane. Here we show that a third fraction of cytochrome c
has to be regarded in the contact sites. However, the
cytochrome c localisation in the contact sites varied,
depending on the presence or absence of VDAC–ANT
complexes (Figs. 1–3). The outer membrane pore VDAC
adopts a different structure when it forms a complex with
the ANT. This VDAC structure has a higher capacity for
binding of hexokinase isotype I [20] and, indicated the
presence of complexes with ANT. The hexokinase type I
isozyme is the predominant enzyme in brain and kidneycortex that remains tightly attached to the mitochondrial
fractions [44]. Thus, hexokinase type I could be used to
isolate the contact site complexes from Triton X-100
extracts of brain or kidney cortex membranes [40]. By
changing the structures of VDAC by dextran (Fig. 3A), or
of the ANT by atractyloside and bongkrekate (Fig. 2A,B) or
of hexokinase by glucose 6-phosphate (Fig. 1B), it was
found that the concentration of cytochrome c in the contact
site fraction was depending on the existence of VDAC–
ANT complexes. The well-known pro-apoptotic effect of
atractyloside and the anti-apoptotic function of bongkrekate
can be explained by altering the VDAC–ANT complexes
followed by changes of the cytochrome c distribution. In
agreement with this, it was recently observed that the anti-
apoptotic Bcl-2 suppresses induction of contact sites [45].
4.2. Cytochrome c is a component of the isolated VDAC–
ANT complexes
The results above suggested that cytochrome c might be
a component of the hexokinase VDAC–ANT complexes
that provide the structure of one type of contact sites. In
earlier investigations, it was found that the complete
VDAC–ANT complex was stable in Triton X-100 extracts
of brain and kidney membranes [23,40]. When such hexo-
kinase contact sites were isolated from brain membrane
extracts, we observed that cytochrome c was also a com-
ponent of the isolated VDAC–ANT complexes and endured
the isolation procedure (Fig. 5).
Neither the nature of the cytochrome c organisation
inside contact sites nor the function of cytochrome c in
the porin–ANT complex is known so far. It can only be
speculated that the negatively charged phospholipid cardi-
olipin that is associated with the ANT [46] may provide the
binding site for the positively charged cytochrome c. In
support of this assumption, we observed that treatment with
Na-borate caused a decrease of cytochrome c in the contact
site fraction. According to the proposal of Taler et al. [43],
the borate ion reacts with the peripheral lysines of cyto-
chrome c. High ionic strength of 200 mM KCl was applied
to elute the hexokinase porin–ANT complex from the anion
exchanger column, but the cytochrome c remained bound to
the complex (Fig. 5). Cortese et al. [47] already described
such a cytochrome fraction in mitochondria that was firmly
bound and resistant to extraction at high ionic strength. This
membrane-bound fraction increased when the volume of the
inter-membrane compartment was decreased. The authors
found that the membrane-bound cytochrome c fraction
readily exchanged with externally added cytochrome c.
The same phenomenon was recently observed as a function
of Bax in cardiomyocytes and isolated heart mitochondria.
Bax-DC released 10% of the total cytochrome c resulting in
30% depression of respiration that could be completely
restored by addition of external cytochrome c [48].
We propose that a special organisation of cytochrome c
in the contact sites or contact site-derived porin–ANT
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organisation could involve partial integration of cytochrome
c into the membrane by binding to cardiolipin that might
distribute along the hydrophobic surface of the porin–ANT
complex. This organisation may thus not need pore forma-
tion for the releasing process. Indeed, a movement of
cardiolipin to the outer leaflet of inner membrane has been
observed preceding apoptosis [49].
4.3. Bax released endogenous cytochrome c from the
reconstituted VDAC–ANT complex without pore formation
The hexokinase porin–ANT complexes were reconsti-
tuted in phospholipid vesicles as described recently [24].
Bax was able to release the cytochrome c originally bound
in the complex, but malate, which was loaded into the same
vesicles, was not liberated Fig. 6A. However, the malate
could be released from the same vesicles through the PT
pore (presumably the ANT), by addition of Ca2 + (Table 1).
Thus, it is concluded that Bax-DC in the range between 400
and 1000 nM did not form pores but detached cytochrome c
from specific binding sites in the porin and ANT complexes.
4.4. Bax binds to hexokinase binding sites
Recently Pastorino et al. [25] described a competition
between hexokinase and Bax for the binding sites at the
mitochondrial surface. It thus appeared that Bax, such as
hexokinase, might have preference to bind to the VDAC
interacting with the ANT. The dissociation of the porin–
ANT complex by bongkrekate firstly changes the distribu-
tion of cytochrome c and secondly decreases the affinity of
hexokinase and presumably Bax to VDAC (Fig. 2B).
Because of these two reasons, bongkrekate suppressed
release of the endogenous cytochrome c from the reconsti-
tuted complexes (Fig. 6B).
4.5. Hexokinase activity inhibits Bax-dependent cytochrome
c release in reconstituted porin–ANT complexes
The ADP produced by active hexokinase stabilises the
VDAC–ANT complexes [39] and thus the enzyme stays
bound to the mitochondrial surface. This may explain why
Bax-DC was unable to displace hexokinase and to liberate
cytochrome c from the reconstituted hexokinase porin–
ANT complex in the presence of hexokinase substrates
glucose and ATP (Fig. 6C). Several recently published
observations in intact cells are explicated by our finding.
It has been described that constitutively active protein
kinase B/Akt-inhibited growth factor withdrawal induced
apoptosis by increased rate of glycolysis [27,50]. Active
protein kinase B was found to increase mitochondrial
binding of hexokinase II in Rat 1a cells and suppressed
cytochrome c release and apoptosis through activity of
hexokinase in the presence of glucose [26]. In agreement
with this, B-cell lines derived from patients with Hodgkin’sdisease, known to have high mitochondrial bound hexoki-
nase activity [51], were resistant against staurosporin-in-
duced apoptosis [52].
All these results strongly suggest that Bax-DC can
specifically release a fraction of mitochondrial cytochrome
c that is organised in a so far unknown way close to or
within the VDAC–ANT complexes. This portion of cyto-
chrome c may be a physiologically fast responding fraction
observed in the early phase of Bax action [9,28]. As this
fraction amounts to maximally 20% of the mitochondrial
cytochrome c, the Bax-DC-dependent release did not block
the electron transport and mitochondrial function [48]. It
has been observed that Bcl-2 and Bcl-xl interact as well
with the reconstituted hexokinase complex and inhibited
the PT pore opening [53]. It was recently described that
Bcl-2 suppressed contact sites [45], suggesting that by this
mechanism, Bcl-2 may interfere with the Bax effect on
cytochrome c release.
On the whole, our results propose that activity of
hexokinase bound to the VDAC–ANT complex can inhibit
the release of both cytochrome c fractions: the Bax-induced
release through interactions with the contact sites, and the
massive release of cytochrome c by swelling and disruption
of the membranes through Ca2 +-dependent opening of the
PT pore.Acknowledgements
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